Non-exudative choroidal and/or macular neovascularizations (NV) represent nowadays a common finding in different retinal disorders. The introduction of non-invasive techniques such as structural optical coherence tomography (OCT) and OCT angiography (OCTA) allowed for easy detection and follow-up of non-exudative NVs. Recognized as a distinct entity, these lesions demonstrate a high variability in terms of pathophysiology, morphology, and prognostic implications. In the absence of a consensus regarding correct classification of subtypes of non-exudative NVs, accurate management through strict follow-up strategies and prompt treatment is required. In this review we offer a comprehensive overview of the non-exudative NV spectrum in various retinal diseases aiming to provide a deeper insight into this clinical entity.
ParodiMBArrigoARomanoF, et al.Hyperreflective foci number correlates with choroidal neovascularization activity in angioid streaks. Invest Ophthalmol Vis Sci2018; 59: 3314–3319.
SpaideRFJaffeGJSarrafD, et al.Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology2020; 127: 616–636.
7.
RudolfMClarkMEChimentoMF, et al.Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci2008; 49: 1200–1209.
SacconiRFragiottaSSarrafD, et al.Towards a better understanding of non-exudative choroidal and macular neovascularization. Prog Retin Eye Res2023; 92: 101113.
10.
SarksSH. New vessel formation beneath the retinal pigment epithelium in senile eyes. Br J Ophthalmol1973; 57: 951–965.
11.
HanutsahaPGuyerDRYannuzziLA, et al.Indocyanine-green videoangiography of drusen as a possible predictive indicator of exudative maculopathy. Ophthalmology1998; 105: 1632–1636.
12.
Amissah-ArthurKNPanneerselvamSNarendranN,et al.Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration. Eye2012; 26: 394–399.
13.
QuerquesGSrourMMassambaN, et al.Functional characterization and multimodal imaging of treatment-naïve “quiescent” choroidal neovascularization. Invest Ophthalmol Vis Sci2013; 54: 6886–6892.
14.
NaritaCWuZRosenfeldPJ, et al.Structural OCT signs suggestive of subclinical nonexudative macular neovascularization in eyes with large drusen. Ophthalmology2020; 127: 637–647.
15.
HirabayashiKYuHJWakatsukiY, et al.OCT risk factors for development of atrophy in eyes with intermediate age-related macular degeneration. Ophthalmol Retina2023; 7: 253–260.
16.
CarnevaliACicinelliMVCapuanoV, et al.Optical coherence tomography angiography: a useful tool for diagnosis of treatment-naïve quiescent choroidal neovascularization. Am J Ophthalmol2016; 169: 189–198.
CheungCMGLaiTYYTeoK, et al.Polypoidal choroidal vasculopathy: consensus nomenclature and non–indocyanine green angiograph diagnostic criteria from the Asia-Pacific ocular imaging society PCV workgroup. Ophthalmology2021; 128: 443–452.
19.
SacconiRSarrafDGarrityS, et al.Nascent type 3 neovascularization in age-related macular degeneration. Ophthalmol Retina2018; 2: 1097–1106.
20.
SacconiRFortePCapuanoV, et al.Optical coherence tomography angiography characterization of evolving lesions in fellow eyes of exudative type 3 macular neovascularization patients. Retina Phila Pa2022; 42: 2075–2082.
21.
SoleckiLLoganadanePGauthierA-S, et al.Predictive factors for exudation of quiescent choroidal neovessels detected by OCT angiography in the fellow eyes of eyes treated for a neovascular age-related macular degeneration. Eye2021; 35: 644–650.
22.
CarnevaliASacconiRQuerquesL, et al.Natural history of treatment-naïve quiescent choroidal neovascularization in age-related macular degeneration using OCT angiography. Ophthalmol Retina2018; 2: 922–930.
23.
YangJZhangQMotulskyEH, et al.Two-Year risk of exudation in eyes with nonexudative age-related macular degeneration and subclinical neovascularization detected with swept source optical coherence tomography angiography. Am J Ophthalmol2019; 208: 1–11.
24.
CapuanoVMiereAQuerquesL, et al.Treatment-Naïve quiescent choroidal neovascularization in geographic atrophy secondary to nonexudative age-related macular degeneration. Am J Ophthalmol2017; 182: 45–55.
25.
Al-SheikhMIafeNAPhasukkijwatanaN, et al.Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography. Retina Phila Pa2018; 38: 220–230.
26.
InvernizziAParrulliSMonteduroD, et al.Outer retinal layer thickening predicts the onset of exudative neovascular age-related macular degeneration. Am J Ophthalmol2021; 231: 19–27.
27.
QuerquesGSacconiRCapuanoV, et al.Treatment-naïve quiescent macular neovascularization secondary to AMD: the 2019 Young Investigator Lecture of Macula Society. Eur J Ophthalmol2021; 31: 3164–3176.
BalaratnasingamCLeeW-KKoizumiH, et al.Polypoidal choroidal vasculopathy a distinct disease or manifestation of many?Retina2016; 36: 1–8.
30.
CheungCMGLeeWKKoizumiH, et al.Pachychoroid disease. Eye Basingstoke2019; 33: 14–33.
31.
GuyerDRYannuzziLASlakterJS, et al.Digital indocyanine-green videoangiography of occult choroidal neovascularization. Ophthalmology1994; 101: 1727–1737.
32.
DansinganiKKBalaratnasingamCNaysanJ,et al.En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina2016; 36: 499–516.
33.
FungATYannuzziLABailey FreundK. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina2012; 32: 1829–1837.
34.
BorrelliEBattistaMGelorminiF, et al.Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease. Sci Rep2020; 10: 20344.
35.
Quaranta-El MaftouhiMMaftouhiEEandiA,et al.Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol2015; 160: 581–587.e1.
36.
SacconiRTomassoLCorbelliE, et al.Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study. Eye Basingstoke2019; 33: 1809–1817.
37.
CarnevaliACapuanoVSacconiR, et al.OCT Angiography of treatment-naïve quiescent choroidal neovascularization in pachychoroid neovasculopathy. Ophthalmol Retina2017; 1: 328–332.
38.
DansinganiKKBalaratnasingamCKlufasMA, et al.Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid Spectrum disease. Am J Ophthalmol2015; 160: 1243–1254.e2.
39.
DansinganiKKGal-OrOSaddaSR, et al.Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of ‘expanded spectra’ – a review. Clin Experiment Ophthalmol2018; 46: 189–200.
40.
BousquetEBonninSMrejenS, et al.Optical coherence tomography angiography of flat irregular pigment epithelium detachment in chronic central serous chorioretinopathy. Retina2018; 38: 629–638.
41.
LumbrosoBRispoliMSavastanoMC. Longitudinal optical coherence tomography-angiography study of type 2 naive choroidal neovascularization early response after treatment. Retina2015; 35: 2242–2251.
42.
ForteRCoscasFSerraR, et al.Long-term follow-up of quiescent choroidal neovascularisation associated with age-related macular degeneration or pachychoroid disease. Br J Ophthalmol2020; 104: 1057–1063.
43.
DoyneR. Choroidal and retinal changes the result of blows on the eyes. Trans Ophthalmol Soc UK1889; 9: 128.
44.
KnappH. On the formation of dark angioid streaks as an unusual metamorphosis of retinal hemorrhage. Arch Ophthalmol1892; 21: 289–292.
45.
VerhoeffFH. Histological findings in a case of angioid streaks. Br J Ophthalmol1948; 32: 531–544.
46.
GurwoodASMastrangeloDL. Understanding angioid streaks. J Am Optom Assoc1997; 68: 309–324.
47.
IssaPCFingerRPHolzFG,et al.Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci2009; 50: 5913–5918.
48.
MarcheseARabioloACorbelliE, et al.Ultra-Widefield imaging in patients with angioid streaks secondary to pseudoxanthoma elasticum. Ophthalmol Retina2017; 1: 137–144.
49.
GeorgalasIPapaconstantinouDKoutsandreaC, et al.Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag2009; 5: 81–89.
50.
LimJIBresslerNMMarshMJ,et al.Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol1993; 116: 414–423.
51.
ChatziralliISaitakisGDimitriouE, et al.ANGIOID STREAKS: a comprehensive review from pathophysiology to treatment. Retina Phila Pa2019; 39: 1–11.
52.
CorbelliECarnevaliAMarcheseA, et al.Optical coherence tomography angiography features of angioid streaks. Retina2018; 38: 2128–2136.
53.
AndreanosKDRotsosTKoutsandreaC, et al.Detection of nonexudative choroidal neovascularization secondary to angioid streaks using optical coherence tomography angiography. Eur J Ophthalmol2017; 27: e140–e143.
54.
LaiginhasRYangJRosenfeldPJ,et al.Nonexudative macular neovascularization – A systematic review of prevalence, natural history, and recent insights from OCT angiography. Ophthalmol Retina2020; 4: 651–661.
55.
Battaglia ParodiMIaconoPRomanoF,et al.Spectral domain optical coherence tomography features in different stages of best vitelliform macular dystrophy. Retina Phila Pa2018; 38: 1041–1046.
56.
GassJDM. Heredodystrophic disorders affecting the pigment epithelium and retina. Stereosc Atlas Macular Dis Diagn Treat1997; 1: 303–435.
57.
ParodiMBArrigoABandelloF. Optical coherence tomography angiography quantitative assessment of macular neovascularization in best vitelliform macular dystrophy. Invest Ophthalmol Vis Sci2020; 61: 61.
LiuGLiuXLiH, et al.Optical coherence tomographic analysis of retina in retinitis Pigmentosa patients. Ophthalmic Res2016; 56: 111–122.
60.
FalfoulYMatriKELHabibiI, et al.OCT-angiography assessing quiescent and active choroidal neovascularization in retinitis pigmentosa associated with PRPH2 pathogenic variant. Eur J Ophthalmol2022; 32: NP98–NP102.
61.
HeierJSBrownDMShahSP, et al.Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes a randomized clinical trial. JAMA Ophthalmol2021; 139: 542–547.
62.
LalezaryMLinSGChanCK, et al.Prophylactic ranibizumab for exudative age-related macular degeneration (AMD) in vulnerable eyes with non-exudative AMD trial (PREVENT): a prospective controlled clinical trial. Investig Ophthalmol Vis Sci2017: 58: 410.
